Advanced search
Publication Cover
Vascular Health and Risk Management Volume 17, 2021 - Issue
Submit an article Journal homepage
93
Views
2
CrossRef citations to date
0
Altmetric
Case Series

Variable and Severe Phenotypic Expression of the “Lebanese Allele” in Two Sisters with Familial Hypercholesterolemia

Johnny ChahineCardiovascular Division, Department of Medicine, University of Minnesota Medical School, Minneapolis, MN, USAView further author information
,
Sarah KreykesCardiovascular Division, Department of Medicine, University of Minnesota Medical School, Minneapolis, MN, USAView further author information
,
Jeremy R Van’t HofCardiovascular Division, Department of Medicine, University of Minnesota Medical School, Minneapolis, MN, USAORCID Iconhttps://orcid.org/0000-0002-9982-3685View further author information
ORCID Icon,
Daniel DuprezCardiovascular Division, Department of Medicine, University of Minnesota Medical School, Minneapolis, MN, USAView further author information
&
Prabhjot NijjarCardiovascular Division, Department of Medicine, University of Minnesota Medical School, Minneapolis, MN, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-8681-1397View further author information
ORCID Icon
Pages 415-419 | Published online: 21 Jul 2021

References

  • de Ferranti SD, Rodday AM, Mendelson MM, Wong JB, Leslie LK, Sheldrick RC. Prevalence of familial hypercholesterolemia in the 1999 to 2012 United States National Health and Nutrition Examination Surveys (NHANES). Circulation. 2016;133(11):1067–1072. doi:10.1161/CIRCULATIONAHA.115.018791
  • Benn M, Watts GF, Tybjaerg-Hansen A, Nordestgaard BG. Mutations causative of familial hypercholesterolaemia: screening of 98 098 individuals from the Copenhagen General Population Study estimated a prevalence of 1 in 217. Eur Heart J. 2016;37(17):1384–1394. doi:10.1093/eurheartj/ehw028
  • Lehrman MA, Schneider WJ, Brown MS, et al. The Lebanese allele at the low density lipoprotein receptor locus. Nonsense mutation produces truncated receptor that is retained in endoplasmic reticulum. J Biol Chem. 1987;262(1):401–410. doi:10.1016/S0021-9258(19)75941-9
  • Fahed AC, Bitar FF, Khalaf RI, Moubarak EM, Azar ST, Nemer GM. The Lebanese allele at the LDLR in normocholesterolemic people merits reconsideration of genotype phenotype correlations in familial hypercholesterolemia. Endocrine. 2012;42(2):445–448. doi:10.1007/s12020-012-9669-0
  • McGowan MP, Hosseini Dehkordi SH, Moriarty PM, Duell PB. Diagnosis and treatment of heterozygous familial hypercholesterolemia. J Am Heart Assoc. 2019;8(24):e013225. doi:10.1161/JAHA.119.013225
  • Sturm AC, Knowles JW, Gidding SS, et al.; Convened by the Familial Hypercholesterolemia F. Clinical genetic testing for familial hypercholesterolemia: JACC scientific expert panel. J Am Coll Cardiol. 2018;72(6):662–680. doi:10.1016/j.jacc.2018.05.044
  • Abifadel M, Rabes JP, Jambart S, et al. The molecular basis of familial hypercholesterolemia in Lebanon: spectrum of LDLR mutations and role of PCSK9 as a modifier gene. Hum Mutat. 2009;30(7):E682–91. doi:10.1002/humu.21002
  • Wang J, Dron JS, Ban MR, et al. Polygenic versus monogenic causes of hypercholesterolemia ascertained clinically. Arterioscler Thromb Vasc Biol. 2016;36(12):2439–2445. doi:10.1161/ATVBAHA.116.308027
  • Willer CJ, Schmidt EM, Sengupta S, et al.; Global Lipids Genetics C. Discovery and refinement of loci associated with lipid levels. Nat Genet. 2013;45:1274–1283.
  • Berberich AJ, Hegele RA. The complex molecular genetics of familial hypercholesterolaemia. Nat Rev Cardiol. 2019;16(1):9–20. doi:10.1038/s41569-018-0052-6
  • Foody JM, Vishwanath R. Familial hypercholesterolemia/autosomal dominant hypercholesterolemia: molecular defects, the LDL-C continuum, and gradients of phenotypic severity. J Clin Lipidol. 2016;10(4):970–986. doi:10.1016/j.jacl.2016.04.009
  • Jansen AC, van Wissen S, Defesche JC, Kastelein JJ. Phenotypic variability in familial hypercholesterolaemia: an update. Curr Opin Lipidol. 2002;13(2):165–171. doi:10.1097/00041433-200204000-00008
  • Khera AV, Won HH, Peloso GM, et al. Diagnostic yield and clinical utility of sequencing familial hypercholesterolemia genes in patients with severe hypercholesterolemia. J Am Coll Cardiol. 2016;67(22):2578–2589. doi:10.1016/j.jacc.2016.03.520
  • Trinder M, Li X, DeCastro ML, et al. Risk of premature atherosclerotic disease in patients with monogenic versus polygenic familial hypercholesterolemia. J Am Coll Cardiol. 2019;74(4):512–522. doi:10.1016/j.jacc.2019.05.043
  • Santos RD, Gidding SS, Hegele RA, et al.; International Atherosclerosis Society Severe Familial Hypercholesterolemia P. Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the international atherosclerosis society severe familial hypercholesterolemia panel. Lancet Diabetes Endocrinol. 2016;4(10):850–861. doi:10.1016/S2213-8587(16)30041-9
  • Catapano AL, Graham I, De Backer G, et al.; Group ESCSD. ESC/EAS guidelines for the management of dyslipidaemias. Eur Heart J. 2016;2016(37):2999–3058. doi:10.1093/eurheartj/ehw272

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.